EyeTechCare
Financials
Estimates*
EUR | 2014 | 2015 |
---|---|---|
Revenues | <1m | <1m |
% growth | - | (3 %) |
EBITDA | - | (3.0m) |
% EBITDA margin | - | (479 %) |
Profit | (3.1m) | (3.4m) |
% profit margin | (477 %) | (538 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€10.0m | Series C | ||
€25.0m | Series D | ||
Total Funding | AUD59.5m |
Recent News about EyeTechCare
EditEye Tech Care specializes in the development and manufacturing of non-invasive medical devices for the treatment of glaucoma. Utilizing advanced focused ultrasound technology, their devices provide a quick, incision-free procedure that can be completed in just five minutes. This innovative approach allows for repeatable treatments, making it a long-term solution for glaucoma management. The company primarily serves ophthalmologists and healthcare providers who treat patients with glaucoma, a condition affecting millions worldwide. Operating in the medical device market, Eye Tech Care's business model revolves around the sale of their CE-marked class IIb medical devices to healthcare institutions. Revenue is generated through direct sales and partnerships with medical distributors. The company is headquartered in Rillieux-la-Pape, France, and is committed to addressing the global health burden of glaucoma, which is a leading cause of blindness.
Keywords: glaucoma, non-invasive, ultrasound, medical device, ophthalmology, CE-marked, healthcare, treatment, innovation, repeatable.